Rankings
▼
Calendar
VCEL Q4 2016 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
Gross Profit
$9M
54.1% margin
Operating Income
-$6M
-35.6% margin
Net Income
-$6M
-37.5% margin
EPS (Diluted)
$-0.25
QoQ Revenue Growth
+51.2%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$526,000
Balance Sheet
Total Assets
$49M
Total Liabilities
$24M
Stockholders' Equity
$25M
Cash & Equivalents
$23M
← FY 2016
All Quarters
Q1 2017 →